Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase

Area of Science:

• Biochemistry
• Structural Biology
• Enzymology

Background:

• Neutral ceramidase (nCDase) is pivotal in regulating ceramide and sphingosine-1-phosphate levels.
• nCDase is an emerging therapeutic target for cancer due to its role in lipid metabolism.
• Understanding nCDase structure and function is key to developing targeted cancer therapies.

Purpose of the Study:

• To determine the crystal structure of human neutral ceramidase (nCDase).
• To elucidate the catalytic mechanism and substrate specificity of nCDase.
• To provide a structural basis for the development of nCDase-targeting cancer drugs.

Main Methods:

• X-ray crystallography of human nCDase in complex with phosphate.
• Flexible ligand docking to predict ceramide binding.
• Comparative analysis with bacterial ceramidases.

Main Results:

• The 2.6-Å crystal structure of human nCDase revealed a deep, hydrophobic active site pocket.
• A eukaryotic-specific subdomain was identified, absent in bacterial counterparts.
• Flexible ligand docking predicted a ceramide binding mode consistent with the phosphate transition state analog.
• nCDase exhibits specificity for ceramide through steric exclusion and recognition of its small hydroxyl head group.

Conclusions:

• Human nCDase employs a novel catalytic strategy for Zn(2+)-dependent amidases.
• The unique active site structure dictates ceramide specificity.
• These findings lay the groundwork for designing nCDase inhibitors for cancer therapy.